|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Acute Physiology and Chronic Health Evaluation Score II (APACHEII) is one of the well-known scoring systems that is used to rule out severity of illness and Acinetobacter baumannii causes severe morbidity especially in ICU. The aim of this study is to evaluate APACHE II score in A. baumannii infected or colonized patients and find out the antimicrobial resistant pattern of isolates. In this case control study, clinical details were recorded among patients admitted to ICU. All the clinical samples like tips (endotraceal aspirates, tips, central line tips, and catheters tips), aspirates, blood, urine, fluid and pus were collected. A. baumannii and other isolates (infection or colonizer) were identified by different biochemical tests. All the clinical details were recorded to calculate APACHE II score. Antimicrobial resistance pattern was performed by disk diffusion method and resistant pattern were analysed according to CLSI guideline 2016. Total of 34 A. baumannii was isolated from critically ill patients. Clinically and microbiologically analyzed that 20 A. baumannii caused infections and rest 14 was isolated as a colonizer. Mean APACHE II Score was 23.94±3.78. While Mean APACHE II score of control cases were 20.01±4.11. A. baumannii causing infections were highly resistant. They showed 100% sensitivity against polymyxins only and 79.4% resistant for imipenem. But colonizers showed better sensitive for amikacin also. APACHE II Score can be a useful tool to predict A. baumannii infections. All the isolated Acinetobacter were highly resistant isolates which restrict the treatment options so it is very essential to treat patients by following all the infection control practices and provide more attention to patients with high APACHE II Score.